Maternal Serum Screen-Reference Range

Maternal serum screening, or the multiple marker test, is a blood test for pregnant woman in the second trimester of pregnancy. The results can be used to determine the risk that the baby has a chromosome disorder or neural tube defect such as spina bifida.

Several substances in the blood are measured in the test, these substances include Alpha-fetoprotein (AFP), Human chorionic gonadotropin (hCG), Unconjugated estriol (uE3), and Inhibin A.

The test results are as follows:

If the levels of hCG and uE3 are normal, and AFP levels are high, then there is a high risk of getting open spina bifida.

If the levels of hCG and uE3 are low, and AFP levels are high, then there is a high risk of getting Anencephaly.

If the levels of hCG are high, the levels of uE3 and AFP are low, and the levels of Inhibin A are high, then there is a high risk of getting Down syndrome.

If the levels of hCG are low, the levels of uE3 are low, and the levels of AFP are Variable, then there is a high risk of getting Edwards syndrome.

It should be noticed that the test will not detect all cases of fetal abnormalities. Therefore, further tests such as high-resolution ultrasound are needed to determine and confirm a diagnosis.

Keywords: 4-marker Screen; AFP Maternal; Maternal Serum AFP; Maternal Serum Screen; Maternal Serum Screening; second Trimester; msAFP; Multiple Marker Test

* The contents of this HTQ Site are for informational and communicational purposes only. The information provided by HTQ, HTQ employees, others appearing on the Site at the invitation of HTQ, or other visitors to the Site is NOT a medical advice.The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the HTQ Site!